Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)
QNTM - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.85M
Close$
$0.01
99.4% downside
Current Fair Value
99.4% downsideOvervalued by 99.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $12.85 Million |
|---|---|
| Enterprise Value | $10.22 Million |
| Earnings per Share | $-8.11 |
| Beta | 0.48 |
| Outstanding Shares | 7,981,356 |
Return
| Return on Equity | -211.25% |
|---|---|
| Return on Assets | -143.87% |
| Return on Invested Capital | -124.40% |
Valuation & Multiples
| P/E Ratio | -0.38 |
|---|---|
| PEG | 0.57 |
| Price to Sales | - |
| Price to Book Ratio | 1.61 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.84 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 12, 2026
EPS
-$0.06
Est. -$0.50Revenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
March 26, 2027
EPS Estimate
-$0.75
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.81%▼ 5.43% |
|---|---|
| Total Invested | $194,285▼ 87.08% |
| Investors Holding | 3▼ 24.00% |
About Quantum BioPharma Ltd.
5 employees
CEO: Raza Bokhari
fsd pharma inc., through its subsidiary, fv pharma inc., produces medical cannabis in canada. the company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based...